Global Med Technologies(R)' Subsidiary, Inlog, Will License EdgeLab to Saint Maurice Hospitals
Saint Maurice Hospitals is a multi-site facility comprising Esquirol andSaint Maurice National Hospitals. The laboratories process 2,000 tests perday and include the following specialties: biochemistry, toxicology,hematology, microbiology and immunology. Twelve analyzers will be connecteddirectly to EdgeLab via Inlog's EdgeLink gateway. The sites will be equippedwith cutting edge "Tablet PC's" for the entry of bacteriology results. Thetotal laboratory solution is completed by Inlog's SapaNet module for stockmanagement and EdgeNet for providing testing results via a webpage.
De Helene VRILLON, head of the Laboratory, stated, "We chose EdgeLabbecause of the quality of their response to our call for tender and Inlog'swillingness to meet our specific needs. The query tool, nosocomial infectioncapability, the orders management, the quality and vigilances functions arealso part of the key features that made our decision."
Since EdgeLab's 1999 introduction into the hospital market as "LaboServeur", it has become a leading Laboratory Information Management System inEurope with more than 150 licensed laboratories. EdgeLab connects with morethan 1,000 analyzers and interchanges data with all major hospital healthcaresoftware packages. It has an intuitive Windows graphical interface and acomprehensive range of laboratory functionality. EdgeLab can be easilyconfigured to meet the business needs of complex multi-site hospitallaboratories as well as small single site hospitals that have much lesscomplexity.
Will Willman, Sr. Vice President of Sales and Marketing EU/ME/Asia atGlobal Med Technologies, commented, "We are very pleased to provide ourcomplete laboratory package to the Saint Maurice Hospitals. Inlog can provideone stop shopping for all the clinical and non-clinical information systemneeds of a laboratory with EdgeLab, SapaNet, EdgeLink and EdgeNet, and SaintMaurice has taken advantage of this. We look forward to helping Saint MauriceHospitals continue to provide quality laboratory services to their physiciansand patients."
About the Saint-Maurice Hospitals
The Saint Maurice Hospitals' umbrella includes the National Hospital ofSaint-Maurice, Esquirol Hospital (Psychiatrics) and a Maternity Unit. TheNational Hospital of Saint-Maurice is an active reference center in thereeducation field including rehabilitation and follow-up care for adults andchildren, as well as care in the area of chronic renal deficiency. It has 417beds at is disposition, admits approximately 4,000 patients and handles nearly10,000 external consultations annually.
About Global Med Technologies, Inc.
Global Med Technologies(R), Inc. is an international medical softwarecompany which develops regulated and non-regulated software products andservices for the healthcare industry. As a leading provider of blood andlaboratory software applications and services, Global Med's products aredeployed in 20 countries and serve over 1,600 transfusion centers, blood banksand laboratories.
Global Med's domestic companies are Wyndgate Technologies(R), whichprovides Vein-to-Vein(R) tracking through its Donor Doc(TM), SafeTrace(R),SafeTrace Tx(R) and ElDorado Donor(TM) software products; eDonor(R), whichprovides a web-based donor relationship management system that integratesrecruitment, scheduling, retention and fulfillment for national as well aslocal community blood centers and hospitals; and PeopleMed(TM), Inc., whichimplements cost-effective customized software validation, consulting andcompliance solutions to hospitals and donor centers.
Global Med's European subsidiary, Inlog, SA, is a leading developer ofdonor center and transfusion management systems as well as cellular therapysoftware, laboratory information systems and quality assurance medicalsoftware systems internationally. Inlog's products include EdgeBlood*,EdgeTrack*, EdgeCell, EdgeLab and SapaNet.
For more information about Global Med's products and services, please call800-996-3428 or visit http://www.globalmedtech.com, http://www.peoplemed.com,http://www.inlog.com, http://www.eDonor.com, and http://www.wyndgate.com.
*FDA 510(k) clearance required prior to sales in the U.S.
This news release may include statements that constitute forward-lookingstatements, usually containing the words "believe," "estimate," "project,""expects" or similar expressions. These statements are made pursuant to thesafe harbor provisions of the Private Securities Litigation Reform Act of1995. Forward-looking statements inherently involve risks and uncertaintiesthat could cause actual results to differ materially from the forward-lookingstatements. By making these forward-looking statements, the Companyundertakes no obligation to update these statements for revisions or changesafter the date of this news release.
SOURCE Global Med Technologies
You May Also Like